RHOLISTIX Trademark

Trademark Overview


On Thursday, April 25, 2019, a trademark application was filed for RHOLISTIX with the United States Patent and Trademark Office. The USPTO has given the RHOLISTIX trademark a serial number of 88401759. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 29, 2023. This trademark is owned by Kadmon Pharmaceuticals, LLC. The RHOLISTIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and pharmaceutical preparations, namely, Anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhy...
rholistix

General Information


Serial Number88401759
Word MarkRHOLISTIX
Filing DateThursday, April 25, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 29, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements


Goods and ServicesPharmaceuticals and pharmaceutical preparations, namely, Anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 10, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKadmon Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWarrendale, PA 15086

Party NameKadmon Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWarrendale, PA 15086

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 29, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2022SOU EXTENSION 5 GRANTED
Tuesday, October 25, 2022SOU EXTENSION 5 FILED
Wednesday, November 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 25, 2022TEAS EXTENSION RECEIVED
Saturday, April 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 21, 2022SOU EXTENSION 4 GRANTED
Thursday, April 21, 2022SOU EXTENSION 4 FILED
Thursday, April 21, 2022TEAS EXTENSION RECEIVED
Saturday, October 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 21, 2021SOU EXTENSION 3 GRANTED
Thursday, October 21, 2021SOU EXTENSION 3 FILED
Thursday, October 21, 2021TEAS EXTENSION RECEIVED
Friday, April 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 28, 2021SOU EXTENSION 2 GRANTED
Wednesday, April 28, 2021SOU EXTENSION 2 FILED
Wednesday, April 28, 2021TEAS EXTENSION RECEIVED
Friday, October 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2020SOU EXTENSION 1 GRANTED
Wednesday, October 28, 2020SOU EXTENSION 1 FILED
Wednesday, October 28, 2020TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 27, 2020ASSIGNED TO LIE
Friday, January 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 16, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 16, 2019NON-FINAL ACTION E-MAILED
Tuesday, July 16, 2019NON-FINAL ACTION WRITTEN
Monday, July 8, 2019ASSIGNED TO EXAMINER
Friday, May 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 29, 2019NEW APPLICATION ENTERED